miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2

Peng Yang1, Jianhua Han2, Shigeng Li2

  • 1Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.

Abstract

Insights

MicroRNA-128-3p (miR-128-3p) levels decrease in sepsis, leading to increased TGFBR2. Restoring miR-128-3p inhibits inflammation and apoptosis by targeting TGFBR2, offering a potential sepsis treatment.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Sepsis involves systemic inflammation and organ dysfunction.
  • MicroRNAs (miRNAs) are implicated in sepsis pathogenesis.
  • The role of miR-128-3p in sepsis is not well understood.

Purpose of the Study:

  • To investigate the regulatory network of miR-128-3p and TGFBR2 in sepsis.
  • To elucidate the mechanism of miR-128-3p in lipopolysaccharide (LPS)-induced sepsis.

Main Methods:

  • Quantitative PCR and Western blot to measure gene and protein expression.
  • Flow cytometry for cell apoptosis analysis.
  • ELISA for cytokine detection.
  • Dual-luciferase reporter and RIP assays to confirm miRNA-target interaction.

Main Results:

  • miR-128-3p was downregulated, and TGFBR2 was upregulated in sepsis patients and LPS-induced cells.
  • miR-128-3p overexpression or TGFBR2 knockdown reduced inflammation and apoptosis.
  • TGFBR2 is a direct target of miR-128-3p, mediating its effects on inflammation and apoptosis.
  • miR-128-3p suppressed the Smad signaling pathway by downregulating TGFBR2.

Conclusions:

  • miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2.
  • This interaction presents a potential therapeutic strategy for sepsis treatment.